StockNews.com lowered shares of Kewaunee Scientific (NASDAQ:KEQU - Free Report) from a buy rating to a hold rating in a research note released on Friday morning.
Kewaunee Scientific Stock Performance
Shares of KEQU traded down $1.36 during midday trading on Friday, hitting $49.69. 31,954 shares of the stock traded hands, compared to its average volume of 22,252. Kewaunee Scientific has a 1-year low of $30.82 and a 1-year high of $71.33. The firm has a market capitalization of $142.71 million, a PE ratio of 7.87 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The business's 50 day moving average price is $58.39 and its two-hundred day moving average price is $47.80.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million for the quarter.
Insider Activity at Kewaunee Scientific
In other Kewaunee Scientific news, VP Douglas J. Batdorff sold 3,470 shares of the company's stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $65.50, for a total value of $227,285.00. Following the completion of the sale, the vice president now directly owns 5,000 shares of the company's stock, valued at approximately $327,500. This represents a 40.97 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Donald T. Gardner III sold 1,257 shares of the company's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the completion of the sale, the chief financial officer now directly owns 21,358 shares of the company's stock, valued at $1,265,675.08. The trade was a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,144 shares of company stock worth $629,216 over the last ninety days. 14.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Kewaunee Scientific
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Minerva Advisors LLC lifted its holdings in Kewaunee Scientific by 4.1% in the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company's stock valued at $6,668,000 after acquiring an additional 4,311 shares during the last quarter. Invesco Ltd. purchased a new stake in Kewaunee Scientific during the fourth quarter valued at about $6,545,000. De Lisle Partners LLP lifted its stake in Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock valued at $1,446,000 after buying an additional 11,511 shares in the last quarter. American Century Companies Inc. lifted its stake in Kewaunee Scientific by 18.0% during the fourth quarter. American Century Companies Inc. now owns 34,293 shares of the technology company's stock valued at $2,122,000 after buying an additional 5,221 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its stake in Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company's stock valued at $1,733,000 after buying an additional 891 shares in the last quarter. 32.69% of the stock is owned by institutional investors and hedge funds.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Recommended Stories
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
